Your browser doesn't support javascript.
loading
123I-iododexetimide preferentially binds to the muscarinic receptor subtype M1 in vivo.
Bakker, Geor; Vingerhoets, Wilhelmina A; van Wieringen, Jan-Peter; de Bruin, Kora; Eersels, Jos; de Jong, Jan; Chahid, Youssef; Rutten, Bart P; DuBois, Susan; Watson, Megan; Mogg, Adrian J; Xiao, Hongling; Crabtree, Michael; Collier, David A; Felder, Christian C; Barth, Vanessa N; Broad, Lisa M; Bloemen, Oswald J; van Amelsvoort, Thérèse A; Booij, Jan.
Affiliation
  • Bakker G; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands Department of Nuclear Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands Geor.bakker@maastrichtuniversity.nl.
  • Vingerhoets WA; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands Department of Nuclear Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • van Wieringen JP; Department of Nuclear Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • de Bruin K; Department of Nuclear Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Eersels J; Department of Nuclear Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • de Jong J; Department of Nuclear Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Chahid Y; Department of Nuclear Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Rutten BP; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
  • DuBois S; Eli Lilly and Co., Indianapolis, Indiana; and.
  • Watson M; Eli Lilly and Co., Indianapolis, Indiana; and.
  • Mogg AJ; Lilly Research Centre, Eli Lilly and Co., Windlesham, Surrey, United Kingdom.
  • Xiao H; Eli Lilly and Co., Indianapolis, Indiana; and.
  • Crabtree M; Lilly Research Centre, Eli Lilly and Co., Windlesham, Surrey, United Kingdom.
  • Collier DA; Lilly Research Centre, Eli Lilly and Co., Windlesham, Surrey, United Kingdom.
  • Felder CC; Eli Lilly and Co., Indianapolis, Indiana; and.
  • Barth VN; Eli Lilly and Co., Indianapolis, Indiana; and.
  • Broad LM; Lilly Research Centre, Eli Lilly and Co., Windlesham, Surrey, United Kingdom.
  • Bloemen OJ; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
  • van Amelsvoort TA; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
  • Booij J; Department of Nuclear Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
J Nucl Med ; 56(2): 317-22, 2015 Feb.
Article de En | MEDLINE | ID: mdl-25593117
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Dexétimide / Récepteur muscarinique / Radio-isotopes de l'iode Limites: Animals / Humans / Male Langue: En Journal: J Nucl Med Année: 2015 Type de document: Article Pays d'affiliation: Pays-Bas
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Dexétimide / Récepteur muscarinique / Radio-isotopes de l'iode Limites: Animals / Humans / Male Langue: En Journal: J Nucl Med Année: 2015 Type de document: Article Pays d'affiliation: Pays-Bas